Opportunity Information: Apply for PAR 13 342
Apply for PAR 13 342
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Revision Requests for Active Alzheimers Disease Core Centers (P30)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866 Aging Research.
- This funding opportunity was created on Aug 30, 2013 and posted on Aug 30, 2013.
- Applicants must submit their applications by Jan 7, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Revision Requests for Active Alzheimers Disease Core Centers (P30)" (Funding Opportunity Number PAR 13-342), was issued by the National Institutes of Health (NIH) through the National Institute on Aging (NIA). It is a discretionary grant program in the health research area and is tied to CFDA 93.866, Aging Research. The announcement was posted on August 30, 2013, and it ultimately closed on January 7, 2017, with an archive date of February 7, 2017. There is no cost sharing or matching requirement, meaning applicants were not expected to provide matching funds as a condition of receiving the award.
The purpose of the opportunity was to invite "revision applications," which were formerly referred to as competing supplements, from institutions that already held an active NIA-supported Alzheimers Disease Core Center award under the P30 mechanism. In practical terms, this was not a call for brand-new Alzheimers Disease Core Centers. Instead, it was a way for currently funded NIA Alzheimers Disease Core Centers to request additional support to expand or adjust the work already being done under their existing center grant. The central theme is expansion of scope, allowing centers to build on established infrastructure and capabilities rather than starting from scratch.
The revisions envisioned under this announcement could take a couple of forms. A center could propose creating a new core, which typically means establishing a new shared resource, service, or centralized function that supports multiple research projects and investigators within the center. Alternatively, a center could propose changes to an existing core, such as modifying the services it provides, adding new capabilities, or otherwise updating the core to address evolving scientific needs in Alzheimers disease research. The mechanism is meant to strengthen and broaden the center's capacity, usually by enhancing shared resources that improve efficiency, collaboration, and scientific output across the center.
One important constraint is that any revision request had to fit within the life of the parent P30 award. The announcement explicitly states that revision applications may not request support beyond the end date of the parent P30. That means the additional activities, new core creation, or core modifications had to be planned and budgeted so they could be completed during the remaining active period of the current Alzheimers Disease Core Center grant, rather than extending the overall project period.
Eligibility was limited to entities that already had an ongoing NIA-supported Alzheimers Disease Core Center (P30) grant, since the entire premise is revising and expanding an existing award. Foreign institutions were not eligible to apply. In addition, non-U.S. components of U.S. organizations were not eligible, and foreign components (as defined by the NIH Grants Policy Statement) were not allowed. In other words, the program was intended to support U.S.-based center infrastructure and activities without foreign components.
For applicants or interested parties needing the official notice, NIH provided an additional information link to the full announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-13-342.html. NIH also listed contact support through the NIH Office of Extramural Research (OER) webmaster for technical issues accessing or linking to the announcement (FBOWebmaster@OD.NIH.GOV), indicating that questions about electronic access rather than scientific scope were routed through that channel.
FAQs: Revision Requests for Active Alzheimers Disease Core Centers (P30) (PAR 13-342)
What is the title of this grant opportunity?
The opportunity is titled "Revision Requests for Active Alzheimers Disease Core Centers (P30)."
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is PAR 13-342.
Which agency and institute issued this opportunity?
This opportunity was issued by the National Institutes of Health (NIH) through the National Institute on Aging (NIA).
What type of program is this?
It is a discretionary grant program in the health research area.
What CFDA number is associated with this opportunity?
This opportunity is tied to CFDA 93.866, Aging Research.
When was the announcement posted?
The announcement was posted on August 30, 2013.
When did the opportunity close?
The opportunity ultimately closed on January 7, 2017.
When was the opportunity archived?
The archive date was February 7, 2017.
Is cost sharing or matching required?
No. There is no cost sharing or matching requirement for this opportunity.
What is the purpose of this opportunity?
The purpose was to invite revision applications (formerly referred to as competing supplements) from institutions that already held an active NIA-supported Alzheimers Disease Core Center award under the P30 mechanism.
Is this a funding opportunity for creating a brand-new Alzheimers Disease Core Center?
No. This was not a call for brand-new Alzheimers Disease Core Centers. It was intended for currently funded NIA Alzheimers Disease Core Centers to request additional support to expand or adjust work under an existing P30 center grant.
What does "revision application" mean in this context?
In this context, a revision application is a request from an existing, actively funded NIA Alzheimers Disease Core Center (P30) to expand or change the scope of the ongoing award, rather than starting a new center award.
What kinds of revisions were envisioned under this announcement?
The announcement described revisions such as (1) creating a new core (a new shared resource, service, or centralized function supporting multiple projects and investigators within the center), or (2) proposing changes to an existing core (modifying services, adding capabilities, or updating the core to meet evolving scientific needs in Alzheimers disease research).
What is meant by "creating a new core"?
Creating a new core generally means establishing a new shared resource, service, or centralized function designed to support multiple research projects and investigators within the Alzheimers Disease Core Center.
What is meant by "changes to an existing core"?
Changes to an existing core can include modifying the services it provides, adding new capabilities, or otherwise updating the core to address evolving scientific needs related to Alzheimers disease research.
How does this opportunity relate to strengthening a center?
The mechanism was intended to strengthen and broaden a center's capacity by enhancing shared resources, improving efficiency and collaboration, and increasing scientific output across the existing center infrastructure.
Can a revision request extend the overall project period of the parent P30 award?
No. Revision applications could not request support beyond the end date of the parent P30 award.
What timing constraint applies to the activities proposed in a revision?
Any additional activities, including new core creation or core modifications, had to be planned and budgeted to fit within the remaining active period of the current Alzheimers Disease Core Center (P30) award.
Who was eligible to apply?
Eligibility was limited to entities that already had an ongoing NIA-supported Alzheimers Disease Core Center (P30) grant.
Are foreign institutions eligible to apply?
No. Foreign institutions were not eligible to apply.
Are non-U.S. components of U.S. organizations eligible?
No. Non-U.S. components of U.S. organizations were not eligible.
Are foreign components allowed under this opportunity?
No. Foreign components (as defined by the NIH Grants Policy Statement) were not allowed under this opportunity.
Where can applicants find the official full announcement?
The full announcement was available at: http://grants.nih.gov/grants/guide/pa-files/PAR-13-342.html
Who should be contacted for technical issues accessing or linking to the announcement?
NIH listed the NIH Office of Extramural Research (OER) webmaster for technical issues accessing or linking to the announcement: FBOWebmaster@OD.NIH.GOV.
What kind of questions is the listed contact intended for?
Based on the information provided, the listed contact was intended for technical issues related to electronic access or linking to the announcement, rather than questions about scientific scope.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: NeuroNEXT Clinical Trials (U01)
Previous opportunity: Education, Interpretation, Visitor Services and Resource Protection for Bureau of Land Management for Colorado.
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 13 342
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 13 342) also looked into and applied for these:
| Funding Opportunity |
|---|
| NeuroNEXT Clinical Trials (U01) Apply for PAR 13 343 Funding Number: PAR 13 343 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening Local Capacity for Scientific Research and Knowledge Management in Health Sectors in Asia Apply for 486 13 000003 Funding Number: 486 13 000003 Agency: Thailand USAID Bangkok Category: Health Funding Amount: $15,000,000 |
| TECHNICAL ASSISTANCE TO OBTAIN STATE AND TERRITORIAL HEALTH DEPARTMENT INPUT FOR NATIONAL HEALTH SECURITY RELATED ACTIVITIES Apply for EP HIT 13 002 Funding Number: EP HIT 13 002 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $500,000 |
| TECHNICAL ASSISTANCE TO OBTAIN LOCAL LEVEL GOVERNMENTAL AND COMMUNITY INPUT FOR NATIONAL HEALTH SECURITY RELATED ACTIVITIES Apply for EP HIT 13 003 Funding Number: EP HIT 13 003 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $500,000 |
| NIDCR Small Grant Program for New Investigators (R03) Apply for PAR 13 348 Funding Number: PAR 13 348 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| NIGMS National Centers for Systems Biology (P50) Apply for PAR 13 351 Funding Number: PAR 13 351 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| R40 Maternal and Child Health Research Program (MCHR) Apply for HRSA 14 007 Funding Number: HRSA 14 007 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| R40 Maternal and Child Health Secondary Data Analysis Studies (MCH SDAS) Apply for HRSA 14 008 Funding Number: HRSA 14 008 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| R40 Maternal and Child Health Policy Analysis Program Apply for HRSA 14 009 Funding Number: HRSA 14 009 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Additional Area (SAC AA) Alabama, California, Federal States of Micronesia, Illinois, Maine, Michigan, Oregon, and Palau Apply for HRSA 14 105 Funding Number: HRSA 14 105 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Technologies To Assess Sleep Health Status in Populations (R43/R44) Apply for RFA HL 14 013 Funding Number: RFA HL 14 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Adaptation of Scalable Technologies to Illuminate the Druggable Genome (U01) Apply for RFA RM 13 010 Funding Number: RFA RM 13 010 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Development of a Knowledge Management Center for Illuminating the Druggable GenomeTitle Here (U54) Apply for RFA RM 13 011 Funding Number: RFA RM 13 011 Agency: National Institutes of Health Category: Health Funding Amount: $3,000,000 |
| Revision Requests for Active Alzheimers Disease Centers (P50) Apply for PAR 13 353 Funding Number: PAR 13 353 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Defining A Comprehensive Reference Profile of Circulating Human Extracellular RNA (U01) Apply for RFA RM 13 014 Funding Number: RFA RM 13 014 Agency: National Institutes of Health Category: Health Funding Amount: $700,000 |
| Advancing the Science of Geriatric Palliative Care (R01) Apply for PA 13 354 Funding Number: PA 13 354 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing the Science of Geriatric Palliative Care (R21) Apply for PA 13 355 Funding Number: PA 13 355 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Advancing the Science of Geriatric Palliative Care (R03) Apply for PA 13 356 Funding Number: PA 13 356 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Centers Without Walls for Collaborative Research in the Epilepsies Sudden Unexpected Death in Epilepsy (SUDEP) (U01) Apply for RFA NS 14 004 Funding Number: RFA NS 14 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Disaster Mental Health Intervention Research Center (P60) Apply for RFA MH 14 090 Funding Number: RFA MH 14 090 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 342", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.